Skip to Main Content

Paper Details

Circulating CD14<sup>+</sup> HLA-DR<sup>lo/-</sup> monocytic cells as a biomarker for epithelial ovarian cancer progression.
Am J Reprod Immunol
5
2021
-DRlo/- monocytic cells, CD11b, CD14, CD14+ HLA-DRlo/- monocytic cells, CD15, CD33, EOC, HLA, HLA-DR, HLA-DRlo, Patients, circulating CD14+ HLA-DRlo/- monocytic cells, circulating monocytic cells, epithelial ovarian cancer, immune suppressive subset, malignancy, monocytic cell, monocytic cells, pancreatic cancer, patient, patients, peripheral blood CD33+ CD11b+ HLA-DR-/low CD14+ CD15- monocytic cells, prostate, renal cell carcinoma, solid malignancies, tumour, women

Datasets

Release 1.2